We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
20/12/2019 09:21 | Maybe Norti could examine the fatty entrails of the blonde pig to see what the future has in store for people in hot countries getting hotter? Through more effective treatment of HIV, we may be able to help them live longer in order to experience starvation. | gwr7 | |
20/12/2019 09:15 | Something which may be of interest. Lagos have recently opened an aids coordination centre. This will be the hub for six regional centres throughout Nigeria. Omega carried out six trials for cd4 in separate locations all successful. So inmo bodes well for the future. This could also be very important for Nigeria as well as Omega in terms of how data can be collected and rapidly processed from various locations. Maybe other countries will look at this and adopt a similar approach. | upomega | |
19/12/2019 18:15 | He did have some very good policies.shame a bit to far left.its a pity coalitions do not work very well | upomega | |
19/12/2019 18:00 | We the Norti Raskal maketh estimations there is a range of 15-30p per share that the food intolerance and infectious diseases might reach. Norti researched a PhD in Econometrics before he became a powerful personage in the realm. Norti dreams of the day he can entertain himself with the corbynated chicken and the abbottopotamus in his dungeon. The corbynated chicken has an evil right eye see the fresnel lines in the lens. Abbottopotamus shows signs of witchery two left shoes on her cloven hooves. | raskal | |
19/12/2019 13:49 | I think we are all still positive upomega, just awaiting the MOH signing....because as Leeds stated there is a lot riding on this.. | barrywhit | |
19/12/2019 13:42 | Why have people began to turn wary that cd4 orders will come out of Nigeria. The way I have read this is that the lead investigator for hiv has submitted their report to the ministry of health recommending that cd4 be used in their hiv programme. Technical data has already been submitted regarding trials which proved successful. We all know how bureaucracy works (slowly). For all we know is that a key signatory is on holiday and unable to sign the final document off. So I am still positive, but it would be nice to get a result before Christmas | upomega | |
19/12/2019 06:50 | True Dibs but I think you will find the MOH have to sign off the tests to allow into their HIV programme...should be any day soon.... see below -- 50,000 tests in January 2020 -- 50,000 tests in February 2020 -- 100,000 tests in March 2020 This order is in addition to the first purchase order for 50,000 tests announced on 16 August 2019. The combined order total for 250,000 tests remains conditional upon the Nigerian Ministry of Health ("MOH") approving the Company's VISITECT(R) CD4 350 test into its national HIV policy, a process which is still ongoing at present. A final delivery schedule will be confirmed once the MOH outcome is known with certainty. | barrywhit | |
18/12/2019 23:55 | I was under the impression the ‘approval̵ | dibs61 | |
18/12/2019 21:19 | Hope so Barry lot riding on them | leedslad001 | |
18/12/2019 21:16 | Who knows Leeds, it is Nigeria after all..Hopefully all will go well.. | barrywhit | |
18/12/2019 21:12 | QuestionI thought MOH was supposed to be signing week ago. does anybody think there is a chance they will shelve this?don't like spending money these regimes Just a thought as we are so close now and have Been dashed before | leedslad001 | |
18/12/2019 19:54 | If we can only get £25m for Food Intolerance i'd rather hang on to it for the time being. | arthur_lame_stocks | |
18/12/2019 19:43 | Raskal the other day you said food intolerance was worth 25p a share, now it is £25m. I suggest you may be King of the Castle but not of arithmetic. | arthur_lame_stocks | |
18/12/2019 18:44 | The stock market generally looks 18 months ahead.so inmo if we get a good rns re cd4 and food tech we should get to good level in a couple of months.for me ideally above 20 p | upomega | |
18/12/2019 17:43 | Not sure Dibs. An opportunistic grab at it for £40m could happen (28p/share) - but I would like to think they can get double that. Norti (and his cadaver tealeaf reading) is probably right though. Uptake of Visitect CD4 is probably going to be slower rather than faster, and take up of Food Detective in China could be the realy game changer in the near future. | longshanks | |
18/12/2019 17:30 | We the Norti Raskal in the Castle have captured an ancient hag accused of Witchcraft. Tomorrow we commence the trial by ordeal and will extract knowledge of the future from her if she survives the ducking stool in my moat. There is much coin to be gathered from the CD4 but this will be over a time not instant. The infectious diseases and food intolerance is the cash producer. This has paid for all the development through thick and thin from "quintessentially English and beyond. This can be sold for £25,000,000 says Norti's alchemist. If he is wrong he will go on my rack followed by the embrace of an iron maiden. Norti Raskal is a just ruler. | raskal | |
18/12/2019 16:46 | longshanks - any thoughts what price ODX in a takeover? | dibs61 | |
18/12/2019 15:52 | They could well report on completing phase 1 of the three-phase programme for WHO prequalification this week. They expected the technical review to be completed together with a decision on the evaluation site by calendar year end, and I doubt much will get done from the 23rd December. We could also get news on the Nigerian MOH approval soon as the CD4 350 orders are conditional on receiving this and delivery is scheduled between January and March 2020. Either way - this is cheap as chips with the price still some way from the house broker target. It is not without risk, but all the runes are looking good and by this time next year the business could be significantly cash-flow positive and paying dividends. That said though, the company is unlikely to be listed this time next year if that pans out: plenty of cash rich businesses out there looking to acquire decent cash generating businesses with niche products and high margins. | longshanks | |
18/12/2019 15:03 | Yep, on tiny volumes too. If there's no stock around then a nice RNS would have an interesting effect. | rivaldo | |
18/12/2019 14:33 | She's edging up again.... | dibs61 | |
17/12/2019 12:57 | We the Norti Raskal have already stated that we control 0.0015 % of a milliard ordinary shares. Does't not knowest what is a milliard? | raskal | |
17/12/2019 12:36 | Naughty As a matter of interest do you own any shares | upomega | |
17/12/2019 12:07 | Only we Norti of the family Raskal is King of the Castle. Not dirty rascals who live in my moat. Who is bernadette? The necromancy failed before an answer was extracted. Norti will examine the entrails of a goat when the portents bid it. Norti's previous corpse spewed out the Zwanzigger now Norti know who he be. Norti will leave his castle to hunt and capture witches a bodkin to mortify their flesh plunged into a witch should yield more knowledge."thou shalt not suffer a witch to live." James I of England VI of Scotland. | raskal | |
16/12/2019 21:54 | Let's hope they give him enough incentive to stay whilst everything comes together | upomega |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions